[1-(2,5-difluorophenyl)cyclopropyl]amine hydrochloride, 95.0%, 500mg

4-Methyl-1H-indole-2,3-dione, 95.0%, 5g

6-Methoxy-3-methyl-2H-isoquinolin-1-one, 96%, 50mg

(S)-2-Amino-2-(3-chlorophenyl)ethanol, 95.0%, 1g

5,6-Dibromopyridin-3-amine, 95.0%, 10g

1-(Pyrazin-2-yl)urea, 95.0%, 100mg

2-(3-Fluorophenyl)oxirane, 98%, 5g

N'-{5-[(2E)-3-(dimethylamino)-2-propenoyl]-4-methyl-1,3-thiazol-2-yl}-N,N-dimethylimidoformamide, 95.0%, 5g

4-Oxo-4-phenylbutyric acid, 98.0%, 50g

3-(Piperidin-4-yl)-1,2,3,4-tetrahydroquinazolin-2-one, 95.0%, 5g

Hypoxanthine, min. 98%, for biochemistry, 5 g, glass packaging

(2-amino-6-methyl-4,5,6,7-tetrahydro-1-benzothien-3-yl)(2,3-dimethoxyphenyl)methanone, 250mg

6-Fluoroindole, 99.0%, 5g